Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Pasulka

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Life Science Alliance|February 28, 2019
Main constraints for RNAi induced by expressed long dsRNA in mouse cellsTomas Demeter, Michaela Vaskovicova, Radek Malik, et al.
Genes & Development|August 16, 2012
Serine phosphorylation and proline isomerization in RNAP II CTD control recruitment of Nrd1Karel Kubicek, Hana Cerna, Peter Holub, et al.
The Journal of Biological Chemistry|November 19, 2010
Recognition of transcription termination signal by the nuclear polyadenylated RNA-binding (NAB) 3 proteinFruzsina Hobor, Roberto Pergoli, Karel Kubicek, et al.
Nucleic Acids Research|March 10, 2012
Air2p is critical for the assembly and RNA-binding of the TRAMP complex and the KOW domain of Mtr4p is crucial for exosome activationPeter Holub, Jana Lalakova, Hana Cerna, et al.
EMBO Reports|May 20, 2024
Functional canonical RNAi in mice expressing a truncated Dicer isoform and long dsRNAValeria Buccheri, Josef Pasulka, Radek Malik, et al.
Nucleic Acids Research|January 21, 2020
The most abundant maternal lncRNA Sirena1 acts post-transcriptionally and impacts mitochondrial distributionSravya Ganesh, Filip Horvat, David Drutovic, et al.
Oncoimmunology|March 24, 2021
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patientsJana Rakova, Iva Truxova, Peter Holicek, et al.
Genome Research|May 20, 2017
Long terminal repeats power evolution of genes and gene expression programs in mammalian oocytes and zygotesVedran Franke, Sravya Ganesh, Rosa Karlic, et al.
Nucleic Acids Research|January 8, 2025
Enhanced RNAi does not provide efficient innate antiviral immunity in miceMarcos Iuri Roos Kulmann, Eliska Taborska, Brigita Benköova, et al.
Cell Death & Disease|March 25, 2023
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patientsPeter Holicek, Iva Truxova, Jana Rakova, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Life Science Alliance|February 28, 2019
Main constraints for RNAi induced by expressed long dsRNA in mouse cellsTomas Demeter, Michaela Vaskovicova, Radek Malik, et al.
Genes & Development|August 16, 2012
Serine phosphorylation and proline isomerization in RNAP II CTD control recruitment of Nrd1Karel Kubicek, Hana Cerna, Peter Holub, et al.
The Journal of Biological Chemistry|November 19, 2010
Recognition of transcription termination signal by the nuclear polyadenylated RNA-binding (NAB) 3 proteinFruzsina Hobor, Roberto Pergoli, Karel Kubicek, et al.
Nucleic Acids Research|March 10, 2012
Air2p is critical for the assembly and RNA-binding of the TRAMP complex and the KOW domain of Mtr4p is crucial for exosome activationPeter Holub, Jana Lalakova, Hana Cerna, et al.
EMBO Reports|May 20, 2024
Functional canonical RNAi in mice expressing a truncated Dicer isoform and long dsRNAValeria Buccheri, Josef Pasulka, Radek Malik, et al.
Nucleic Acids Research|January 21, 2020
The most abundant maternal lncRNA Sirena1 acts post-transcriptionally and impacts mitochondrial distributionSravya Ganesh, Filip Horvat, David Drutovic, et al.
Oncoimmunology|March 24, 2021
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patientsJana Rakova, Iva Truxova, Peter Holicek, et al.
Genome Research|May 20, 2017
Long terminal repeats power evolution of genes and gene expression programs in mammalian oocytes and zygotesVedran Franke, Sravya Ganesh, Rosa Karlic, et al.
Nucleic Acids Research|January 8, 2025
Enhanced RNAi does not provide efficient innate antiviral immunity in miceMarcos Iuri Roos Kulmann, Eliska Taborska, Brigita Benköova, et al.
Cell Death & Disease|March 25, 2023
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patientsPeter Holicek, Iva Truxova, Jana Rakova, et al.
Pageof 3